| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/14/2023 | 473.07% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 08/17/2023 | 473.07% | HC Wainwright & Co. | → $2 | Reiterates | Buy → Buy |
| 06/29/2023 | 473.07% | HC Wainwright & Co. | → $2 | Initiates Coverage On | → Buy |
| 04/05/2023 | 1619.2% | Truist Securities | → $6 | Reinstates | → Hold |
| 12/12/2022 | 473.07% | Morgan Stanley | $6 → $2 | Maintains | Equal-Weight |
| 11/17/2022 | 3911.46% | Baird | $24 → $14 | Maintains | Outperform |
| 11/01/2022 | 1619.2% | Morgan Stanley | $8 → $6 | Maintains | Equal-Weight |
| 11/01/2022 | 6776.79% | Baird | $31 → $24 | Maintains | Outperform |
| 11/01/2022 | — | Cowen & Co. | Downgrades | Outperform → Market Perform | |
| 09/06/2022 | 8782.52% | Baird | $34 → $31 | Maintains | Outperform |
| 08/24/2022 | 2192.26% | Morgan Stanley | $9 → $8 | Maintains | Equal-Weight |
| 08/23/2022 | 4484.53% | Truist Securities | $25 → $16 | Maintains | Buy |
| 06/06/2022 | 2478.8% | Morgan Stanley | $14 → $9 | Maintains | Equal-Weight |
| 05/24/2022 | 3911.46% | Morgan Stanley | $15 → $14 | Maintains | Equal-Weight |
| 08/13/2021 | 9642.12% | Baird | → $34 | Initiates Coverage On | → Outperform |
| 05/26/2021 | 6490.26% | Morgan Stanley | $24 → $23 | Maintains | Equal-Weight |
| 04/13/2021 | 8782.52% | Jefferies | → $31 | Initiates Coverage On | → Buy |
| 04/13/2021 | 6776.79% | Morgan Stanley | → $24 | Initiates Coverage On | → Equal-Weight |
| 04/13/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 04/13/2021 | 9069.05% | Truist Securities | → $32 | Initiates Coverage On | → Buy |
What is the target price for Instil Bio (TIL)?
The latest price target for Instil Bio (NASDAQ: TIL) was reported by HC Wainwright & Co. on November 14, 2023. The analyst firm set a price target for $2.00 expecting TIL to rise to within 12 months (a possible 473.07% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Instil Bio (TIL)?
The latest analyst rating for Instil Bio (NASDAQ: TIL) was provided by HC Wainwright & Co., and Instil Bio reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Instil Bio (TIL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Instil Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Instil Bio was filed on November 14, 2023 so you should expect the next rating to be made available sometime around November 14, 2024.
Is the Analyst Rating Instil Bio (TIL) correct?
While ratings are subjective and will change, the latest Instil Bio (TIL) rating was a reiterated with a price target of $0.00 to $2.00. The current price Instil Bio (TIL) is trading at is $0.35, which is within the analyst's predicted range.